Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly ' s Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs

Goldman Sachs analysts identified a substantial opportunity in the manufacturing sector for new obesity therapeutics, as demand for these treatments escalates. Goldman Sachs projects the global obesity market to potentially reach $100 billion by 2030, with a more optimistic outlook suggesting it…#goldmansachs #novonordiskasnvo #elilillyandcompany #glp1 #elililly #novonordisk #elilillys #avantorinc #api #thermofisherinc
Source: Reuters: Health - Category: Consumer Health News Source Type: news